{"disease":{"id":"peripheral-artery-disease","name":"peripheral artery disease"},"drugs":{"marketed":[{"drug_id":"xarelto","indication_name":"Prevention of atherothrombotic events in symptomatic peripheral artery disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"rivaroxaban","indication_name":"Prevention of atherothrombotic events in symptomatic peripheral artery disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."},{"drug_id":"oral-p2y12-receptor-blocker","indication_name":"Reduction of thrombotic cardiovascular events in patients with atherosclerotic disease, including those with a recent ischemic stroke or peripheral artery disease (PAD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oral P2Y12 receptor blocker","company_name":"Italian Society of Invasive Cardiology","drug_phase":"marketed","molecular_target":"P2Y12 adenosine diphosphate receptor on platelet surface","drug_class":"Antiplatelet agent; P2Y12 receptor antagonist; Thienopyridine or non-thienopyridine class","quality_score":22,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04834843","title":"Temporal Trends of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":700000,"lead_sponsor_name":"Wonju Severance Christian Hospital","has_results":false},{"nct_id":"NCT04824729","title":"A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients","phase":"","overall_status":"COMPLETED","enrollment_count":227613,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03909022","title":"Assessing Best Medical Treatment Patterns of Patients With Symptomatic Peripheral Arterial Occlusive Disease in Germany","phase":"","overall_status":"UNKNOWN","enrollment_count":60000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03258983","title":"Alpha-linolenic Acid and the Risk of ASCVD","phase":"","overall_status":"COMPLETED","enrollment_count":57053,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT02425345","title":"Women's Health Initiative Strong and Healthy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":49331,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT01732822","title":"A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":13885,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05635370","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol","phase":"","overall_status":"COMPLETED","enrollment_count":10398,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT07318610","title":"Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":7050,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT06115213","title":"The North Kynouria Project","phase":"NA","overall_status":"UNKNOWN","enrollment_count":7000,"lead_sponsor_name":"University Hospital, Ioannina","has_results":false},{"nct_id":"NCT02504216","title":"Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6564,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT03448029","title":"RECCORD (Recording Courses of Vascular Diseases) Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin e.V.","has_results":false},{"nct_id":"NCT06022653","title":"Asan Aorta and Peripheral Registry","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04536038","title":"Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":5176,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03186391","title":"Exercise Testing in Peripheral Artery Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04401761","title":"A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs","phase":"","overall_status":"COMPLETED","enrollment_count":3189,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04393389","title":"Acotec DCB Post Market Clinical Follow-up","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Acotec Scientific Co., Ltd","has_results":false},{"nct_id":"NCT06231966","title":"Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2462,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04347200","title":"REGistry of Long-term AnTithrombotic TherApy-1","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","has_results":false},{"nct_id":"NCT03048890","title":"VascTrac Peripheral Arterial Disease (PAD) Study","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Palo Alto Veterans Institute for Research","has_results":false},{"nct_id":"NCT03496948","title":"Telephone Health Coaching and Remote Exercise Monitoring for Peripheral Artery Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":1982,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT01790243","title":"LEVANT 2 Safety Registry","phase":"NA","overall_status":"COMPLETED","enrollment_count":1189,"lead_sponsor_name":"C. R. Bard","has_results":true},{"nct_id":"NCT01597453","title":"NOR-SYS: The Norwegian Stroke in the Young Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1062,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT04903912","title":"Campania Registry On Peripheral Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT05620095","title":"Durg Coated Balloon Angioplasty in Infrapopliteal Lesions","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03044002","title":"BIOTRONIK 4French for AMBulatory Peripheral Intervention","phase":"","overall_status":"COMPLETED","enrollment_count":821,"lead_sponsor_name":"Biotronik AG","has_results":false},{"nct_id":"NCT03266861","title":"Lactate Increase in Peripheral Artery Disease","phase":"","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04776434","title":"SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":723,"lead_sponsor_name":"M.A. Med Alliance S.A.","has_results":false},{"nct_id":"NCT03921905","title":"Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.","phase":"","overall_status":"COMPLETED","enrollment_count":713,"lead_sponsor_name":"Mario Negri Institute for Pharmacological Research","has_results":false},{"nct_id":"NCT05009602","title":"Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":604,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT06250790","title":"Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Pauls Stradins Clinical University Hospital","has_results":false},{"nct_id":"NCT05078814","title":"The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Chimei Medical Center","has_results":false},{"nct_id":"NCT06407154","title":"Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd Wave","phase":"","overall_status":"COMPLETED","enrollment_count":578,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06687590","title":"Serranator POINT FORCE Registry","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Cagent Vascular LLC","has_results":false},{"nct_id":"NCT05628948","title":"Vascular Lab Resource (VLR) Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT07112547","title":"Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04475783","title":"Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":478,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT04474717","title":"Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":476,"lead_sponsor_name":"Ryazan State Medical University","has_results":false},{"nct_id":"NCT04165629","title":"Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Clinical Centre of Serbia","has_results":false},{"nct_id":"NCT03241459","title":"Safety and Efficacy of the SurVeil™ Drug-Coated Balloon","phase":"NA","overall_status":"COMPLETED","enrollment_count":446,"lead_sponsor_name":"SurModics, Inc.","has_results":true},{"nct_id":"NCT03064126","title":"RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT04027244","title":"Leg Ischaemia Management Collaboration","phase":"","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT06300450","title":"Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06686121","title":"Improving Mobility After Revascularization in Peripheral Artery Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":386,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT02554266","title":"Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries","phase":"","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"C. R. Bard","has_results":false},{"nct_id":"NCT03516929","title":"Assessment of Carotid Artery Stenosis and Lower Limb Peripheral Ischemia Prior to CABG","phase":"NA","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Mr Ihab Ali","has_results":false},{"nct_id":"NCT04058626","title":"TEsting for Arterial Disease in Diabetes (TrEAD) Study","phase":"","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":true},{"nct_id":"NCT07374601","title":"The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03668821","title":"Frailty in Vascular Patients Undergoing Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT04298567","title":"Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03421561","title":"ILLUMENATE Pivotal Post-Approval Study (PAS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Spectranetics Corporation","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}